Choroidal Melanoma
Choroidal melanoma is a type of cancer that occurs in the choroid, a layer of blood vessels and connective tissue between the retina and the sclera in the eye. It can lead to vision problems and may require treatment to manage.
Choroidal Melanoma: Belzupacap Sarotalocan Treatment
We are studying a new treatment for people with primary indeterminate lesions or small choroidal melanoma. The goal is to see if it is more effective and safe compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you diagnosed with a small choroidal melanoma or an indeterminate lesion that is growing?
- Do you have any active eye infections or other eye diseases in the eye being studied?
- Have you had any eye surgery or procedures that might affect how the study drug is given?
- Have you ever had treatment for your eye condition in the last 6 months?
- Do you have any known allergies or sensitivities to the study drug or laser?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Belzupacap Sarotalocan
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
04002: Universitats-Augenklinik
Graz, Austria
Medical University Of Vienna
04001: Augenheilkunde und Optometrie
Vienna, Austria
UZ Leuven
Ophthalmology
Heverlee, Belgium
Sponsor: Aura Biosciences Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.